ERK1/2 pathway-mediated differentiation of IGF-1-transfected spinal cord-derived neural stem cells into oligodendrocytes

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Shi, Bo ^a   Ding, Jianxun ^b   Liu, Yi ^a   Zhuang, Xinming ^a   Zhuang, Xiuli ^b   Chen, Xuesi ^b   Fu, Changfeng ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMID DNA; SOMATOMEDIN C; VIRUS VECTOR; HYBRID PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; SPINAL CORD NERVE CELL; TRANSGENICS; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEWBORN; PLASMID; PREGNANCY; PRIMARY CELL CULTURE; REPORTER GENE; SPINAL CORD; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURAL STEM CELLS; OLIGODENDROGLIA; PLASMIDS; PREGNANCY; PRIMARY CELL CULTURE; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SPINAL CORD; TRANSFECTION;

EID: 84940340334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106038     Document Type: Article

References (38)

1. La Spada A, Ranum LP (2010) Molecular genetic advances in neurological disease: special review issue. Hum Mol Gente 19: R1-3.
2. Sasaki T, Sakuma J, Ichikawa T, Matsumoto M, Tiwari P, et al. (2002) Effects of methylprednisolone on axonal depression induced by hypoxia, γ-aminobutyric acid, and (+/-)-8-hydroxy-dipropylaminotetralin hydrobromide. Neurosurgery 51: 1477-1483. (Pubitemid 36098697)
3. Furlan JC, Noonan V, Cadotte DW, Fehlings MG (2011) Timing of decompressive surgery of spinal cord after traumatic spinal cord injury: an evidence-based examination of pre-clinical and clinical studies. J Neurotrauma 28: 1371-1399.
4. Finnerup N, Jensen T (2004) Spinal cord injury pain-mechanisms and treatment. Eur J Neurol 11: 73-82. (Pubitemid 38230781)
5. Cadotte DW, Fehlings MG (2011) Spinal cord injury: a systematic review of current treatment options. Clin Orthop Relat R 469: 732-741.
6. Varma AK, Das A, Wallace Gt, Barry J, Vertegel AA, et al. (2013) Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers. Neurochem Res 38: 895-905.
7. Grossman RG, Frankowski RF, Burau KD, Toups EG, Crommett JW, et al. (2012) Incidence and severity of acute complications after spinal cord injury. J Neurosurg Spine 17: 119-128.
8. Sandock DS, Gothe BG, Bodner DR (1995) Trimethoprim-sulfamethoxazole prophylaxis against urinary tract infection in the chronic spinal cord injury patient. Spinal Cord 33: 156-160.
9. Gage FH (2000) Mammalian Neural Stem Cells. Science 287: 1433-1438.
10. Abematsu M, Nakashima K (2014) Transplantation of neural stem cells with valproate for spinal cord injury. Neuroprotection and Regeneration of the Spinal Cord. Springer Japan. 247-253 p.
11. Azari MF, Mathias L, Ozturk E, Cram DS, Boyd RL, et al. (2010) Mesenchymal stem cells for treatment of CNS injury. Curr Neuropharmacol 8: 316-323.
12. Cao QL, Zhang YP, Howard RM, Walters WM, Tsoulfas P, et al. (2001) Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol 167: 48-58. (Pubitemid 32066408)
13. Shihabuddin LS, Horner PJ, Ray J, Gage FH (2000) Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. J Neurosci 20: 8727-8735.
14. Sabelström H, Stenudd M, Frisén J (2013) Neural stem cells in the adult spinal cord. Exp Neurol.
15. Cheng CM, Mervis RF, Niu S-L, Salem N, Witters LA, et al. (2003) Insulin-like growth factor 1 is essential for normal dendritic growth. J Neurosci Res 73: 1-9. (Pubitemid 36791365)
16. Niblock MM, Brunso-Bechtold JK, Riddle DR (2000) Insulin-like growth factor I stimulates dendritic growth in primary somatosensory cortex. J Neurosci 20: 4165-4176. (Pubitemid 30365687)
17. Yanagiuchi A, Miyake H, Nomi M, Takenaka A, Fujisawa M (2009) Modulation of the microenvironment by growth factors regulates thein vivogrowth of skeletal myoblasts. Bju Int 103: 1569-1573.
18. Kooijman R (2006) Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth F R 17: 305-323.
19. Tzeng S-F (2002) Neural progenitors isolated from newborn rat spinal cords differentiate into neurons and astroglia. J Biomed Sci 9: 10-16.
20. Park SY, Park J, Sim SH, Sung MG, Kim KS, et al. (2011) Enhanced differentiation of human neural stem cells into neurons on graphene. Adv Mater 23: H263-267.
21. Hung K-S, Tsai S-H, Lee T-C, Lin J-W, Chang C-K, et al. (2007) Gene transfer of insulin-like growth factor-I providing neuroprotection after spinal cord injury in rats. J Neurosurg-Spine 6: 35-46. (Pubitemid 47066038)
22. Yao DL, West N, Bondy C, Brenner M, Hudson L, et al. (1995) Cryogenic spinal cord injury induces astrocytic gene expression of insulin-like growth factor I and insulin-like growth factor binding protein 2 during myelin regeneration. J Neurosci Res 40: 647-659.
23. Yao D-L, Liu X, Hudson LD, Webster Hd (1996) Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis. Life Sci 58: 1301-1306. (Pubitemid 26109595)
24. Almad A, Sahinkaya FR, McTigue DM (2011) Oligodendrocyte fate after spinal cord injury. Neurotherapeutics 8: 262-273.
25. Gensert JM, Goldman JE (1997) Endogenous progenitors remyelinate demyelinated axons in the Adult CNS. Neuron 19: 197-203. (Pubitemid 27333005)
26. D'Ercole AJ, Ye P, Calikoglu A, Gutierrez-Ospina G (1996) The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13: 227-255. (Pubitemid 126715878)
27. Barres B, Jacobson M, Schmid R, Sendtner M, Raff M (1993) Does oligodendrocyte survival depend on axons? Curr Biol 3: 489-497.
28. Ye P, D'Ercole AJ (1999) Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-α-induced injury. Endocrinology 140: 3063-3072. (Pubitemid 30650620)
29. Mason J, Ye P, Suzuki K, D'ercole A, Matsushima G (2000) Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20: 5703-5708. (Pubitemid 30636897)
30. Rubinfeld H, Seger R (2004) The ERK cascade as a prototype of MAPK signaling pathways. MAP Kinase Signaling Protocols. 1-28.
31. Xiao J, Ferner AH, Wong AW, Denham M, Kilpatrick TJ, et al. (2012) Extracellular signal-regulated kinase 1/2 signaling promotes oligodendrocyte myelination in vitro. J Neurochem 122: 1167-1180.
32. Ishii A, Furusho M, Bansal R (2013) Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. J Neurosci 33: 175-186.
33. Pernet V, Hauswirth WW, Di Polo A (2005) Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo. J Neurochem 93: 72-83. (Pubitemid 40463517)
34. Baron W, Metz B, Bansal R, Hoekstra D, de Vries H (2000) PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci 15: 314-329. (Pubitemid 30193804)
35. Younes-Rapozo V, Felgueiras LO, Viana NL, Fierro IM, Barja-Fidalgo C, et al. (2009) A role for the MAPK/ERK pathway in oligodendroglial differentiation in vitro: stage specific effects on cell branching. Int J Dev Neurosci 27: 757-768.
36. Oh M-J, Seo TB, Kwon K-B, Yoon S-J, Elzi DJ, et al. (2009) Axonal outgrowth and Erk1/2 activation by training after spinal cord injury in rats. J Neurotraum 26: 2071-2082.
37. Leppä S, Saffrich R, Ansorge W, Bohmann D (1998) Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. Embo J 17: 4404-4413. (Pubitemid 28362630)
38. Gil GA, Bussolino DF, Portal MM, Alfonso Pecchio A, Renner ML, et al. (2004) c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cells. Mol Biol Cell 15: 1881-1894. (Pubitemid 38401836)